BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29316191)

  • 1. Microbiota and the liver.
    Shen TD; Pyrsopoulos N; Rustgi VK
    Liver Transpl; 2018 Apr; 24(4):539-550. PubMed ID: 29316191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
    de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
    Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal immunosuppressor induces stable gut microbiota after liver transplantation.
    Jiang JW; Ren ZG; Lu HF; Zhang H; Li A; Cui GY; Jia JJ; Xie HY; Chen XH; He Y; Jiang L; Li LJ
    World J Gastroenterol; 2018 Sep; 24(34):3871-3883. PubMed ID: 30228781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota, Liver Diseases, and Alcohol.
    Cassard AM; Gérard P; Perlemuter G
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota changes and chronic hepatitis C virus infection.
    Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The gut microbiome is important in chronic liver disease].
    Christensen E
    Ugeskr Laeger; 2019 Jan; 181(2):. PubMed ID: 30618372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome.
    Sidhu M; van der Poorten D
    Aust Fam Physician; 2017; 46(4):206-211. PubMed ID: 28376573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the gut microbiome in graft fibrosis after pediatric liver transplantation.
    Qin T; Fu J; Verkade HJ
    Hum Genet; 2021 May; 140(5):709-724. PubMed ID: 32920649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Doycheva I; Leise MD; Watt KD
    Transplantation; 2016 Jan; 100(1):61-8. PubMed ID: 26647107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease Progression.
    Mungamuri SK; Vijayasarathy K
    Crit Rev Oncog; 2020; 25(1):57-70. PubMed ID: 32865911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH).
    Duarte SMB; Stefano JT; Oliveira CP
    Ann Hepatol; 2019; 18(3):416-421. PubMed ID: 31036494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and liver diseases.
    Tilg H; Cani PD; Mayer EA
    Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
    Huang W; Kong D
    Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and health.
    Kc D; Sumner R; Lippmann S
    Postgrad Med; 2020 Apr; 132(3):274. PubMed ID: 31566046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.